Publication | Closed Access
Long-Term Follow-Up of Myopic Choroidal Neovascularization Treated with Ranibizumab
65
Citations
21
References
2011
Year
Intravitreal ranibizumab seems to be an effective and safe therapeutic procedure to treat CNV in highly myopic eyes, with a high proportion of patients gaining or stabilizing BCVA at a 3-year follow-up.
| Year | Citations | |
|---|---|---|
Page 1
Page 1